Ashima brings nearly two decades of experience across clinical medicine, healthcare strategy, and life sciences consulting. As an Associate Partner within Prescient’s Competitive Strategy practice, she advises leading pharmaceutical and biotechnology companies on strategic decisions that shape portfolio investments, competitive positioning, launch preparedness, and long-term growth.
A physician by training, Ashima graduated with distinction from Bharati Vidyapeeth University, Pune, India and pursued advanced training in infertility management and IVF before completing OBGYN residency programs at several of India’s premier medical institutions. Her clinical background continues to provide the scientific rigor and practical perspective that underpin her consulting work.
Since entering healthcare consulting in 2011, Ashima has become a trusted advisor to Fortune 500 pharmaceutical companies across North America, Europe, APAC, and the Middle East. Her expertise spans competitive intelligence, primary research, conference intelligence, war gaming, scenario planning, competitive simulations, and future landscape assessments. She is known for translating complex scientific and market dynamics into clear, actionable strategies that support high-stakes decision-making.
Ashima has partnered with clients across a wide range of therapeutic areas, including women’s health, vaccines, contraception, anti-infectives, cardiovascular and metabolic disorders, nephrology, hematology, oncology, and rare diseases. Her experience spans the product lifecycle- from early clinical development and target opportunity profiling to launch planning, lifecycle management, commercialization strategy, competitive positioning, and business development evaluations.
Known for her strong client partnerships and strategic thinking, Ashima helps organizations navigate uncertainty, anticipate competitive change, and make confident business decisions.
Ashima describes herself as a physician-turned-strategist who turns complex science into confident commercial decisions.
